Capivasertib-Fulvestrant Therapy Increases PFS in HR-Positive Breast Cancer
Findings seen in patients with hormone receptor-positive advanced breast cancer with relapse, progression during aromatase inhibitor treatment
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.